MedPath

Impact of Rotational Atherectomy on Coronary Microcirculation

Not Applicable
Recruiting
Conditions
Stable Angina
Coronary Artery Disease
Interventions
Diagnostic Test: coronary pressure/temperature sensor-tipped guidewire
Diagnostic Test: Angiography-derived index of microcirculatory resistance (IMRangio)
Registration Number
NCT05771961
Lead Sponsor
Lithuanian University of Health Sciences
Brief Summary

The purpose of this observational study is to compare the impact of rotational atherectomy to conventional stenting and to investigate how it may affect coronary microcirculation in patients with calcified coronary artery lesions and stable CAD.

The study's objectives are to:

* investigate the impact of rotational atherectomy on the prevalence of post-percutaneuos coronary intervention coronay microvascular dysfunction;

* investigate the impact of conventional stenting on the prevalence of post-percutaneuos coronary intervention coronay microvascular dysfunction; and

* compare the impact of both percutaneuos coronary interventions on coronary microvascular dysfunction.

Patients with calcified lesions will be enrolled prospectively and will have serial invasive and non-invasive microvascular testing prior to and after rotational atherectomy or conventional stenting.

Detailed Description

Rotational atherectomy (RA) is a medical procedure used to treat patients with severe atherosclerosis, a condition that causes plaque buildup within the artery walls, resulting in narrowing of the blood vessels and decreased blood flow to the heart. RA is a technique that involves breaking up and removing plaque from the artery with a small, high-speed rotating burr.

However, RA is not without risks. One of the major risks associated with RA is the potential damage to the artery wall and surrounding tissue. This can lead to complications such as bleeding, blood clots, or injury to the heart or other organs. Additionally, the high-speed rotation of the burr can generate heat, which may damage the artery wall or cause the release of harmful particles into the bloodstream.

Another hypothesized risk of RA is its impact on microcirculation, which refers to the smallest blood vessels in the body. RA can cause disruption to these vessels, leading to a decrease in blood flow and potentially causing damage to tissues and organs that depend on them.

The purpose of this study is to look into the effect of rotational atherectomy on coronary microcirculation.

Recruitment & Eligibility

Status
RECRUITING
Sex
All
Target Recruitment
300
Inclusion Criteria
  • Patient diagnosed with stable coronary artery calcified lesion requiring Percutaneous coronary intervention
Exclusion Criteria
  • patients with a history of old myocardial infarction or history of coronary artery bypass grafting (CABG) or Percutaneous coronary intervention PCI
  • Patients with signs of chronic infection, prolong usage of corticosteroids or compromised immune system
  • patients had contraindication of adenosine triphosphate (ATP);
  • had a history of liver or renal function dysfunction
  • Patients with dementia
  • Patients being referred to CABG
  • unable to provide informed consent;
  • had pregnancy or life span < 1 year.
  • Presence of sever structural valvular heart disease
  • Presence of significant left main disease
  • Unability to measure the index of microcirculatory resistance due to (death or retraction from the study ...etc)
  • Inability to perform successful PCI

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Conventional StentingAngiography-derived index of microcirculatory resistance (IMRangio)Patients who are scheduled to have conventional stenting will be labeled in this group; patients in this group will have invasive and non-invasive microvascular testing before and after the conventional stenting procedure.
Rotational AtherectomyAngiography-derived index of microcirculatory resistance (IMRangio)Patients who are scheduled to have rotational atherectomy will be labeled in this group; patients in this group will have invasive and non-invasive microvascular testing before and after the rotational atherectomy procedure.
Conventional Stentingcoronary pressure/temperature sensor-tipped guidewirePatients who are scheduled to have conventional stenting will be labeled in this group; patients in this group will have invasive and non-invasive microvascular testing before and after the conventional stenting procedure.
Rotational Atherectomycoronary pressure/temperature sensor-tipped guidewirePatients who are scheduled to have rotational atherectomy will be labeled in this group; patients in this group will have invasive and non-invasive microvascular testing before and after the rotational atherectomy procedure.
Primary Outcome Measures
NameTimeMethod
The incidence of coronary microvascular dysfunction1 day

Microcirculatory dysfunction will be defined as having an IMR value ≥ 25 U and a CFR value \< 2.5 U or angio IMR ≥ 25 U

Secondary Outcome Measures
NameTimeMethod
Rate of Major adverse cardiovascular events1 year

composite of nonfatal stroke, nonfatal myocardial infarction, heart failure, target vessel revascularization and cardiovascular death.

The incidence of coronary microvascular dysfunction1 year

Microcirculatory dysfunction will be defined as having an IMR value ≥ 25 U and a CFR value \< 2.5 U or angio IMR ≥ 25 U

Seattle Angina Questionnaire score1 year

Evaluates the severity of angina symptoms, physical limitations, and quality of life

Trial Locations

Locations (1)

Lithuanian University of Health Sciences

🇱🇹

Kaunas, Lithuania

© Copyright 2025. All Rights Reserved by MedPath